Richard Sullivan is Professor of Cancer and Global Health at King’s College London, and Director of the King’s Institute of Cancer Policy and co-Director of the Conflict and Health Research Group. His research interests extend from global cancer to conflict and health. Sullivan has worked on a number of Lancet and Lancet Oncology commissions, currently the Lancet Commission on Global Diagnostics and the Lancet Oncology European Cancer Research Commission. Sullivan’s research teams have major programs in capacity building in conflict and health and humanitarian medicine, particularly in the Middle East and North Africa, as well as programmes in women’s health and cancer, digital innovation (virtual-reality enhanced surgery), and a wide range of global health security projects. Global cancer research programs cover cancer systems strengthening, affordability, value particularly and political economy, global radiotherapy, social welfare, and cancer care in conflict. Sullivan qualified in medicine and trained in surgery (urology), gaining his PhD in Biochemistry from University College London. Sullivan has also led R&D programs in the pharmaceutical industry and was Clinical Director of Cancer Research UK between 1999 and 2008. As a former member of British Army Intelligence & Security Group he also many years working on biosecurity and counterproliferation issues, including recent deployments to Ebola outbreaks in West Africa, Democratic Republic of the Congo, and the COVID-19 pandemic.
